5 Best Healthcare Stocks For the Long Term

2. InMode Ltd. (NASDAQ:INMD)

PE Ratio (TTM): 15.72

Number of Hedge Fund Holders: 30

InMode Ltd. (NASDAQ:INMD) is an Israeli healthcare company operating in the medical aesthetics space. Earlier this month, InMode Ltd. (NASDAQ:INMD) rose after the company posted strong guidance. InMode Ltd. (NASDAQ:INMD) said its Q4 revenue will fall in the range of $133.2 million to $133.4 million, while its full-year 2022 revenue will total between $453.9 million and $454.1 million. The consensus estimate for the fourth quarter revenue was $129.45 million. InMode Ltd. (NASDAQ:INMD) said its EPS in the quarter was expected to come in the range of $0.73-$0.74, as compared to the consensus of $0.65. InMode Ltd. (NASDAQ:INMD) will release its quarterly results on February 14.

Jim Simons’ Renaissance Technologies is the biggest stakeholder of InMode Ltd. (NASDAQ:INMD) as of the end of the third quarter. The fund has a $67 million stake in InMode Ltd. (NASDAQ:INMD). Another notable stakeholder in InMode Ltd. (NASDAQ:INMD) according to Insider Monkey’s database is Israel Englander’s Millennium Management which owns a $31.3 million stake. Overall, out of the 920 hedge funds tracked by Insider Monkey, 30 hedge funds had stakes in InMode Ltd. (NASDAQ:INMD) as of the end of the third quarter.